Feiba NF (Anti-Inhibitor Coagulant Complex Vials) 1000 E

FEIBA NF (Anti-Inhibitor Coagulant Complex) is a hemostatic agent used to control bleeding in patients with hemophilia. It contains factors to promote blood clotting. Store at room temperature and handle with care.

Strength

1000 E

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Takeda Pharmaceutical

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

FEIBA NF is used to treat and prevent bleeding episodes in people with hemophilia A or B who have inhibitors. It works by providing clotting factors that help control bleeding. This medication is also used during surgeries or procedures to reduce bleeding risk. It is not a cure but helps manage bleeding episodes when they occur.

Side Effects

FEIBA NF helps restore normal clotting function during bleeding episodes. Users may experience temporary relief from bleeding symptoms as the medication takes effect. Some individuals report improved mobility or comfort after treatment. Effects vary based on the severity of the bleeding and individual response.

Precautions & Warnings

FEIBA NF should be stored at room temperature and protected from light. Always check the expiration date before use. Use only as directed by a healthcare professional. Avoid shaking the vial to prevent damage to the product. Keep out of reach of children and pets.

Avoid Interactions

FEIBA NF may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Combining it with certain medications could increase the risk of clotting issues. Always inform your healthcare provider about all medications you are taking before using FEIBA NF.

Frequently Asked Questions

FEIBA NF is used to treat and prevent bleeding in people with hemophilia who have inhibitors.

Store FEIBA NF at room temperature and protect it from light. Do not freeze or refrigerate.

Yes, FEIBA NF may be used before or during surgery to reduce bleeding risk in patients with hemophilia.

Common side effects may include headache, nausea, or fever. Serious side effects are rare but require immediate medical attention.

FEIBA NF is prescribed for children with hemophilia who have inhibitors, but dosing and safety should be determined by a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.